Literature DB >> 16495542

Protection against heterologous Burkholderia pseudomallei strains by dendritic cell immunization.

Stephen J Elvin1, Gareth D Healey, Angie Westwood, Stella C Knight, James E Eyles, E Diane Williamson.   

Abstract

Burkholderia pseudomallei, the causative agent of melioidosis, is a gram-negative bacterium which can cause either chronic infections or acute lethal sepsis in infected individuals. The disease is endemic in Southeast Asia and northern Australia, but little is known about the mechanisms of protective immunity to the bacterium. In this study, we have developed a procedure to utilize dendritic cells in combination with CpG oligodeoxynucleotides as a vaccine delivery vector to induce protective immune responses to various strains of B. pseudomallei. Our results show that strong cell-mediated immune responses were generated, while antibody responses, although low, were detectable. Upon virulent challenge with B. pseudomallei strain K96243, NCTC 4845, or 576, animals immunized with dendritic cells that were pulsed with heat-killed K96243 and matured in the presence of CpG 1826 showed significant levels of protection. These results show that a vaccine strategy that actively targets dendritic cells can evoke protective immune responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16495542      PMCID: PMC1418668          DOI: 10.1128/IAI.74.3.1706-1711.2006

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  Repeated administration of synthetic oligodeoxynucleotides expressing CpG motifs provides long-term protection against bacterial infection.

Authors:  D M Klinman; J Conover; C Coban
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 2.  Dendritic cells: specialized and regulated antigen processing machines.

Authors:  I Mellman; R M Steinman
Journal:  Cell       Date:  2001-08-10       Impact factor: 41.582

Review 3.  Regulation of T cell immunity by dendritic cells.

Authors:  A Lanzavecchia; F Sallusto
Journal:  Cell       Date:  2001-08-10       Impact factor: 41.582

Review 4.  Antigen presentation and T cell stimulation by dendritic cells.

Authors:  Pierre Guermonprez; Jenny Valladeau; Laurence Zitvogel; Clotilde Théry; Sebastian Amigorena
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

5.  Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide or proteins.

Authors:  S M Jones; J F Ellis; P Russell; K F Griffin; P C F Oyston
Journal:  J Med Microbiol       Date:  2002-12       Impact factor: 2.472

6.  Role of reactive nitrogen and oxygen intermediates in gamma interferon-stimulated murine macrophage bactericidal activity against Burkholderia pseudomallei.

Authors:  K Miyagi; K Kawakami; A Saito
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

7.  An Inv/Mxi-Spa-like type III protein secretion system in Burkholderia pseudomallei modulates intracellular behaviour of the pathogen.

Authors:  Mark P Stevens; Michael W Wood; Lowrie A Taylor; Paul Monaghan; Pippa Hawes; Philip W Jones; Timothy S Wallis; Edouard E Galyov
Journal:  Mol Microbiol       Date:  2002-11       Impact factor: 3.501

8.  Model of differential susceptibility to mucosal Burkholderia pseudomallei infection.

Authors:  Boping Liu; Ghee Chong Koo; Eu Hian Yap; Kim Lee Chua; Yunn-Hwen Gan
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

9.  Burkholderia pseudomallei interferes with inducible nitric oxide synthase (iNOS) production: a possible mechanism of evading macrophage killing.

Authors:  P Utaisincharoen; N Tangthawornchaikul; W Kespichayawattana; P Chaisuriya; S Sirisinha
Journal:  Microbiol Immunol       Date:  2001       Impact factor: 1.955

10.  A mutant of Burkholderia pseudomallei, auxotrophic in the branched chain amino acid biosynthetic pathway, is attenuated and protective in a murine model of melioidosis.

Authors:  T Atkins; R G Prior; K Mack; P Russell; M Nelson; P C F Oyston; G Dougan; R W Titball
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

View more
  18 in total

1.  Burkholderia pseudomallei proteins presented by monocyte-derived dendritic cells stimulate human memory T cells in vitro.

Authors:  Patcharaporn Tippayawat; Maneerat Pinsiri; Darawan Rinchai; Donporn Riyapa; Amornrat Romphruk; Yunn-Hwen Gan; Raymond L Houghton; Philip L Felgner; Richard W Titball; Mark P Stevens; Edouard E Galyov; Gregory J Bancroft; Ganjana Lertmemongkolchai
Journal:  Infect Immun       Date:  2010-11-01       Impact factor: 3.441

2.  Migration of dendritic cells facilitates systemic dissemination of Burkholderia pseudomallei.

Authors:  Natasha L Williams; Jodie L Morris; Catherine M Rush; Natkunam Ketheesan
Journal:  Infect Immun       Date:  2014-07-28       Impact factor: 3.441

3.  Low-dose exposure of C57BL/6 mice to burkholderia pseudomallei mimics chronic human melioidosis.

Authors:  Laura Conejero; Natasha Patel; Melanie de Reynal; Sara Oberdorf; Joanne Prior; Philip L Felgner; Richard W Titball; Francisco J Salguero; Gregory J Bancroft
Journal:  Am J Pathol       Date:  2011-05-05       Impact factor: 4.307

4.  In Vitro and In Vivo studies of monoclonal antibodies with prominent bactericidal activity against Burkholderia pseudomallei and Burkholderia mallei.

Authors:  Shimin Zhang; Shaw-Huey Feng; Bingjie Li; Hyung-Yong Kim; Joe Rodriguez; Shien Tsai; Shyh-Ching Lo
Journal:  Clin Vaccine Immunol       Date:  2011-03-30

5.  Present and future therapeutic strategies for melioidosis and glanders.

Authors:  D Mark Estes; Steven W Dow; Herbert P Schweizer; Alfredo G Torres
Journal:  Expert Rev Anti Infect Ther       Date:  2010-03       Impact factor: 5.091

Review 6.  Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei.

Authors:  Sara K Bondi; Joanna B Goldberg
Journal:  Expert Rev Vaccines       Date:  2008-11       Impact factor: 5.217

7.  The fraction 1 and V protein antigens of Yersinia pestis activate dendritic cells to induce primary T cell responses.

Authors:  R Kingston; F Burke; J H Robinson; P A Bedford; S M Jones; S C Knight; E D Williamson
Journal:  Clin Exp Immunol       Date:  2007-07-23       Impact factor: 4.330

8.  A case report of melioidosis in a diabetic patient in a union territory.

Authors:  Esther Paul; M Sudhagar; S Anandhalakshmi; Shanthi Mathias
Journal:  Australas Med J       Date:  2013-08-31

9.  Protective response to subunit vaccination against intranasal Burkholderia mallei and B. pseudomallei challenge.

Authors:  Gregory C Whitlock; Arpaporn Deeraksa; Omar Qazi; Barbara M Judy; Katherine Taylor; Katie L Propst; Angie J Duffy; Kate Johnson; G Barrie Kitto; Katherine A Brown; Steven W Dow; Alfredo G Torres; D Mark Estes
Journal:  Procedia Vaccinol       Date:  2010

Review 10.  Burkholderia vaccines: are we moving forward?

Authors:  Leang-Chung Choh; Guang-Han Ong; Kumutha M Vellasamy; Kaveena Kalaiselvam; Wen-Tyng Kang; Anis R Al-Maleki; Vanitha Mariappan; Jamuna Vadivelu
Journal:  Front Cell Infect Microbiol       Date:  2013-02-05       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.